SEC Form 4 · accession 0001209191-15-007304
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher J OConnell
Officer — See Remarks
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 9:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 26, 2015 | A | 98,706 | — | A | 98,706 | D | |
| Ordinary SharesF1 | Jan 26, 2015 | A | 2,654 | — | A | 2,654 | I | by ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $48.70 | Jan 26, 2015 | A | 15,401 | A | — | Oct 30, 2016 | Ordinary Shares | 15,401 | 15,401 | D |
| Employee Stock Option (right to buy)F3 | $47.77 | Jan 26, 2015 | A | 17,794 | A | — | Oct 29, 2017 | Ordinary Shares | 17,794 | 17,794 | D |
| Employee Stock Option (right to buy)F4 | $36.24 | Jan 26, 2015 | A | 33,113 | A | — | Oct 27, 2018 | Ordinary Shares | 33,113 | 33,113 | D |
| Employee Stock Option (right to buy)F5 | $35.92 | Jan 26, 2015 | A | 33,408 | A | — | Aug 3, 2019 | Ordinary Shares | 33,408 | 33,408 | D |
| Employee Stock Option (right to buy)F6 | $36.12 | Jan 26, 2015 | A | 27,686 | A | — | Nov 2, 2019 | Ordinary Shares | 27,686 | 27,686 | D |
| Employee Stock Option (right to buy)F7 | $37.53 | Jan 26, 2015 | A | 70,984 | A | — | Aug 2, 2020 | Ordinary Shares | 70,984 | 70,984 | D |
| Employee Stock Option (right to buy)F8 | $34.88 | Jan 26, 2015 | A | 84,060 | A | — | Aug 1, 2021 | Ordinary Shares | 84,060 | 84,060 | D |
| Employee Stock Option (right to buy)F9 | $38.81 | Jan 26, 2015 | A | 75,548 | A | — | Jul 30, 2022 | Ordinary Shares | 75,548 | 75,548 | D |
| Employee Stock Option (right to buy)F10 | $41.60 | Jan 26, 2015 | A | 2,404 | A | — | Oct 29, 2022 | Ordinary Shares | 2,404 | 2,404 | D |
| Employee Stock Option (right to buy)F11 | $55.32 | Jan 26, 2015 | A | 60,250 | A | — | Jul 29, 2023 | Ordinary Shares | 60,250 | 60,250 | D |
| Employee Stock Option (right to buy)F12 | $55.32 | Jan 26, 2015 | A | 1,808 | A | — | Jul 29, 2023 | Ordinary Shares | 1,808 | 1,808 | D |
| Employee Stock Option (right to buy)F13 | $62.76 | Jan 26, 2015 | A | 1,594 | A | — | Jul 28, 2024 | Ordinary Shares | 1,594 | 1,594 | D |
| Employee Stock Option (right to buy)F14 | $62.76 | Jan 26, 2015 | A | 56,852 | A | — | Jul 28, 2024 | Ordinary Shares | 56,852 | 56,852 | D |
Explanation of responses
- F1Represents shares of Medtronic plc ("New Medtronic") acquired pursuant to the merger (the "Merger") of a wholly-owned subsidiary of New Medtronic with and into Medtronic, Inc. ("Medtronic"), with Medtronic surviving as a wholly-owned subsidiary of New Medtronic, which was consummated after and conditioned on New Medtronic's acquisition of Covidien plc, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Medtronic common share was cancelled and converted into the right to receive one New Medtronic ordinary share. Under the terms of the Merger, the officer received cash in lieu of fractional shares of New Medtronic and restricted stock units were rounded up to the nearest whole share.
- F10This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F11This option to purchase 60,250 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 60,250 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F12This option to purchase 1,808 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F13This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F14This option to purchase 56,852 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 56,852 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F2This option to purchase 15,401 ordinary shares of New Medtronic for $48.70 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 15,401 Medtronic common stock shares for $48.70 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F3This option to purchase 17,794 New Medtronic ordinary shares for $47.77 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 17,794 Medtronic common stock shares for $47.77 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F4This option to purchase 33,113 New Medtronic ordinary shares for $36.24 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 33,113 Medtronic common stock shares for $36.24 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F5This option to purchase 33,408 New Medtronic ordinary shares for $35.92 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 33,408 Medtronic common stock shares for $35.92 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F6This option to purchase 27,686 New Medtronic ordinary shares for $36.12 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 27,686 Medtronic common stock shares for $36.12 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F7This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F8This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F9This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
Remarks
Exhibit List Exhibit 24 - Power of Attorney